参考文献/References:
[1] 程佳琪,聂泽华,游 云,等.10例十二指肠乳头腺瘤内镜切除回顾分析[J].胃肠病学和肝病学杂志,2024,33:59-64.
Cheng JQ,Nie ZH,You Y,et al.Retrospective analysis of endoscopic resection of duodenal papilla adenoma[J].Chin J Gastroenterol Hepatol,2024,33:59-64.
[2]Nappo G,Gentile D,Galvanin J,et al.Trans-duodenal ampullectomy for ampullary neoplasms:early and long-term outcomes in 36 consecutive patients[J].Surg Endosc,2020,34:4358-4368.
[3]程佳琪,聂占国.内镜下切除十二指肠乳头部腺瘤的研究进展[J].现代消化及介入诊疗,2022,27:1352-1356.
Cheng JQ,Nie ZG.Research progress of endoscopic resection of duodenal papillary adenoma[J].Mod Interv Diagn Treat Gastroenterol,2022,27:1352-1356.
[4]金春燕,杨 华,王 雷,等.内镜下十二指肠乳头腺瘤切除术后出血原因分析及列线图模型构建[J].现代消化及介入诊疗,2024,29:398-402,406.
Jin CY,Yang H,Wang L,et al.Analysis of causes of bleeding after endoscopic duodenal papillary adenoma resection and establishment of prediction model[J].Mod Interv Diagn Treat Gastroenterol,2024,29:398-402,406.
[5]Vanbiervliet G,Strijker M,Arvanitakis M,et al.Endoscopic management of ampullary tumors:European Society of Gastrointestinal Endoscopy(ESGE)Guideline[J].Endoscopy,2021,53:429-448.
[6]Adler DG,Qureshi W,Davila R,et al.The role of endoscopy in ampullary and duodenal adenomas[J].Gastrointest Endosc,2006,64:849-854.
[7]张淑琴,李雅萍.CHS-DRG付费改革对医院医疗质量和运行效率影响的实证分析[J].卫生软科学,2024,38:10-15.
Zhang SQ,Li YP.Empirical analysis of the impact of CHS-DRG payment reform on hospital medical quality and operational efficiency[J].Soft Sci Health,2024,38:10-15.
[8]周美珍,郑 盼,郭佳奕,等.基于DRG绩效标准化时间效率和床位效率对临床科室的评价研究[J].中国医院统计,2023,30:203-207.
Zhou MZ,Zheng P,Guojia Y,et al.Evaluation on standardized time efficiency and bed efficiency model for clinical departments on DRG performance management[J].Chin J Hosp Stat,2023,30:203-207.
[9]蒋为秀,鲍志鹏,何 英,等.疾病诊断相关分组支付背景下介入导管室护士医疗成本意识现状及影响因素分析[J].介入放射学杂志,2025,34:85-90.
Jiang WX,Bao ZP,He Y,et al.Under the regulation of “disease diagnosis-related group payment” the medical cost consciousness status of nurses working in interventional catheterization room and the analysis of its influencing factors[J].J Interv Radiol,2025,34:85-90.
[10]乔新伟,邱煜婷,李 鹏,等.内镜下十二指肠乳头切除术后短期不良事件危险因素的初步探索[J].首都医科大学学报,2023,44:982-989.
Qiao XW,Qiu YT,Li P,et al.Preliminary study on risk factors of short-term adverse events after endoscopic papillectomy[J].J Cap Med Univ,2023,44:982-989.
[11]张 祎,张成武,黄东胜,等.胰腺神经内分泌肿瘤患者腹腔镜术后住院时间延长的危险因素分析[J].肝胆胰外科杂志,2023,35:151-155,163.
Zhang Y,Zhang CW,Huang DS,et al.Risk factors of prolonged length of hospital stay after laparoscopic surgery for patients with pancreatic neuroendocrine tumors[J].J Hepatopancreatobiliary Surg,2023,35:151-155,163.
[12]吴兆荣,王 倩,殷 芹,等.经颈静脉肝内门体分流术后住院时间延长影响因素分析及预测模型的构建[J].介入放射学杂志,2025,34:418-424.
Wu ZR,Wang Q,Yin Q,et al.Analysis of factors influencing prolonged length of hospital stay after transjugular intrahepatic portosystemic shunt and construction of its prediction model[J].J Interv Radiol,2025,34:418-424.
[13]Charlson ME,Carrozzino D,Guidi J,et al.Charlson comorbidity index:a critical review of clinimetric properties[J].Psychother Psychosom,2022,91:8-35.
[14]王文丹,王 磊,柴 晨,等.年龄校正查尔森合并症指数预测急性A型主动脉夹层患者的病死率[J].中华急诊医学杂志,2023,32:76-81.
Wang WD,Wang L,Chai C,et al.Age-adjusted Charlson comorbidity index predicts mortality in patients with acute type A aortic dissection[J].Chin J Emerg Med,2023,32:76-81.
[15]陈 希,吴 硕,张 丽.年龄校正查尔森合并症指数及使用AN69-ST或AN69-oXiris膜材对行CRRT的脓毒症合并急性肾损伤患者预后的影响[J].现代医学,2023,51:741-746.
Chen X,Wu S,Zhang L.Effect of age-corrected Charson's syndrome index and the use of AN69-ST or AN69-oXiris membrane on the prognosis of septic patients with acute renal injury undergoing CRRT[J].Mod Med J,2023,51:741-746.
[16]付 佳,肖海敏,武 曦,等.年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J].中华普通外科学文献(电子版),2023,17:336-341.
Fu J,Xiao HM,Wu X,et al.Value of age-adjusted Charlson comorbidity index in assessing perioperative complications for laparoscopic colorectal cancer[J].Chin Arch Gen Surg Electron Ed,2023,17:336-341.
[17]鲁为朋,徐庆春,孙礼侠,等.POSSUM、aCCI评分用于老年胆总管结石患者LCBDE围手术期并发症预测效能比较[J].山东医药,2024,64:67-69.
Lu WP,Xu QC,Sun LX,et al.Comparison of POSSUM and aCCI scores in predicting perioperative complications of LCBDE in elderly patients with common bile duct stones[J].Shandong Med J,2024,64:67-69.
[18]Cai CY,Tao LY,Li DX,et al.The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma[J].Scand J Gastroenterol,2024,59:333-343.
[19]贾颖田,林可可,郭少波,等.慢性病患者中医传统功法康复训练促进与阻碍因素的Meta整合[J].护理学杂志,2024,39:16-21.
Jia YT,Lin KK,Guo SB,et al.Meta-synthesis of facilitators and barriers of traditional Chinese medicine exercise rehabilitation training in patients with non-communicable chronic diseases[J].J Nurs Sci,2024,39:16-21.
[20]王晨欢,王子恺.十二指肠乳头肿瘤的内镜诊治研究进展[J].中国微创外科杂志,2024,24:217-223.
Wang CH,Wang ZK.Research progress of endoscopic diagnosis and treatment of duodenal papilla tumor[J].Chin J Minim Invasive Surg,2024,24:217-223.
[21]胡海一,张澍田.内镜下十二指肠乳头切除术对十二指肠乳头腺瘤的治疗价值[J].临床和实验医学杂志,2020,19:415-417.
Hu HY,Zhang ST.The therapeutic value of endoscopic papillectomy for duodenal papillary adenoma[J].J Clin Exp Med,2020,19:415-417.
[22]王域玲,高 杰,施新岗.十二指肠非乳头区腺瘤的诊治进展[J].中华消化内镜杂志,2020,37:149-152.
Wang YL,Gao J,Shi XG.Progress in diagnosis and treatment of non-papillary adenoma of duodenum[J].Chin J Dig Endosc,2020,37:149-152.
[23]孟 睿,周 林,倪牧含,等.内窥镜在十二指肠乳头腺瘤诊断及治疗中的应用研究进展[J].山东医药,2022,62:99-102.
Meng R,Zhou L,Ni MH,et al.Progress in the application of endoscopy in the diagnosis and treatment of duodenal papillary adenoma[J].Shandong Medicine,2022,62:99-102.
[24]叶可柯,顾剑锋,张星鑫.内镜十二指肠乳头肿瘤切除术研究进展[J].中国医学创新,2022,19:164-169.
Ye KK,Gu JF,Zhang XX.Recent progress in endoscopic papillectomy tumor resection[J].Med Innov China,2022,19:164-169.
[25]Wu L,Liu F,Zhang N,et al.Endoscopic pancreaticobiliary drainage with overlength stents to prevent delayed perforation after endoscopic papillectomy:a pilot study[J].World J Gastroenterol,2020,26:7036-7045.
(收稿日期:2025-07-15)
(本文编辑:元 禾)